Infographics | Free Shipping | Cash on Delivery | Email : orders@mynutramart.com | Call : +91-876 2090 777 (9am to 7pm)
References:

 

References:

1. Craik FIM, Salthouse TA. Handbook of Aging and Cognition. Hillsdale, NJ: Erlbaum, 1992.

2. Smith GE, Petersen RC, Parisi JE, et al. Definition, course, and outcome of mild cognitive impairment. Aging Neuropsychol Cogn 1996;3:141–7.

3. Brayne C, Gill C, Paykel ES, et al. Cognitive decline in an elderly population—a two wave study of change. Psychological Study of Medicine 1995;25:673–83.

4. Youngjohn JR, Larrabee GJ, Crook TH. Discriminating age-associated memory impairment and Alzheimer’s disease. Psychol Assess 1992;4:54–9.

5. Hänninen T. Age-associated memory impairment: A neuropsychological and epidemiological study. Neurologian klinikan julkaisusarja 1996;39 [abstract].

6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: American Psychiatric Association, 1994, 684.

7. Levy R. Aging-associated cognitive decline. Int Psychogeriatr 1994;6:63–8 [review].

8. Rubin EH, Storandt M, Miller JP, et al. A prospective study of cognitive function and onset of dementia in cognitively healthy elders. Arch Neurol 1998;55(3):395–401.

9. Bolla KI, Lindgren KN, Bonaccorsy C, Bleecker ML. Memory complaints in older adults: Fact or fiction? Arch Neurol 1991;48:61–4.

10. Lezak M. Neuropsychological Assessment, 3rd ed. New York: Oxford, 1995.

11. Spreen O, Strauss E. A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York: Oxford, 1991.

12. La Rue A. Aging and Neuropsychological Assessment. New York: Plenum, 1992.

13. Nussbaum, PD, ed. Handbook of Neuropsychology and Aging. New York: Plenum, 1997.

14. Ferris SH, Kluger A. Commentary on age-associated memory impairment, age-related cognitive decline and mild cognitive impairment. Aging Neuropsychol Cogn 1996;3:148–53.

15. Rediess S, Caine ED. Aging, cognition, and DSM-IV. Aging Neuropsychol Cogn 1996;3:105–17.

16. Solfrizzi V, Panza F, Torres F, et al. High monounsaturated fatty acids intake protects against age-related cognitive decline. Neurology 1999;52(8):1563–9.

17. Jarvis MJ. Does caffeine enhance absolute levels of cognitive performance? Psychopharmacology (Berl) 1993;110(1–2):45–52.

18. Joseph JA, Shukitt-Hale B, Denisova NA, et al. Long-term dietary strawberry, spinach, or vitamin E supplementation retards the onset of age-related neuronal signal-transduction and cognitive behavioral deficits. J Neurosci 1998;18(19):8047–55.

19. Perrig WJ, Perrig P, Stahelin HB. The relation between antioxidants and memory performance in the old and very old. J Am Geriatr Soc 1997;45(6):718–24.

20. White LR, Petrovitch H, Ross GW, et al. Brain aging and midlife tofu consumption. J Am Coll Nutr 2000;19:242–55.

21. Di Carlo A, Baldereschi M, Maggi S, et al. Prevalence and risk factors of age-related cognitive decline: The Italian longitudinal study on aging (ILSA). American Academy of Neurology, 50th Annual Meeting [abstract] P04.103.

22. Kilander L, Nyman H, Boberg M, et al. Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension 1998;31(3):780–6.

23. Williams P, Lord SR. Effects of group exercise on cognitive functioning and mood in older women. Aust N Z J Public Health 1997;21(1):45–52.

24. Emery CF, Huppert FA, Schein RL. Relationships among age, exercise, health, and cognitive function in a British sample. Gerontologist 1995;35(3):378–85.

25. West RL, Crook TH. Video training of imagery for mature adults. Appl Cogn Psychol 1991;6: 307–20.

26. Caprio-Prevette MD, Fry PS. Memory enhancement program for community-based older adults: development and evaluation. Exp Aging Res 1996;22(3):281–303 [review].

27. Abraham IL, Neundorfer MM, Currie LJ. Effects of group interventions on cognition and depression in nursing home residents. Nurs Res 1992;41(4):196–202.

28. Cipolli C, Chiari G. [Effects of L-acetylcarnitine on mental deterioration in the aged: initial results.] Clin Ter 1990;132(6 Suppl):479–510 [in Italian].

29. Salvioli G, Neri M. L-acetylcarnitine treatment of mental decline in the elderly. Drugs Exp Clin Res 1994;20(4):169–76.

30. Genazzani E. [A controlled clinical study on the efficacy of L-acetylcarnitine in the treatment of mild to moderate mental deterioration in the aged. Conclusions.] Clin Ter 1990;132(6 Suppl):511–2.

31. Garzya G, Corallo D, Fiore A, et al. Evaluation of the effects of L-acetylcarnitine on senile patients suffering from depression. Drugs Exp Clin Res 1990;16(2):101–6.

32. Bonavita E. Study of the efficacy and tolerability of L-acetylcarnitine therapy in the senile brain. Int J Clin Pharmacol Ther Toxicol 1986;24(9):511–6.

33. Passeri M, Iannuccelli M, Ciotti G, et al. Mental impairment in aging: selection of patients, methods of evaluation and therapeutic possibilities of acetyl-L-carnitine. Int J Clin Pharmacol Res 1988;8(5):367–76.

34. Maggioni M, Picotti GB, Bondiolotti GP, et al. Effects of phosphatidylserine therapy in geriatric patients with depressive disorders. Acta Psychiatr Scand 1990;81(3):265–70.

35. Cenacchi T, Bertoldin T, Farina C, et al. Cognitive decline in the elderly: a double-blind, placebo-controlled multicenter study on efficacy of phosphatidylserine administration. Aging (Milano) 1993;5(2):123–33.

36. Hindmarch I, Fuchs HH, Erzigkeit H. Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes. Int Clin Psychopharmacol 1991;6:31–43.

37. Balestreri R, Fontana L, Astengo F. A double-blind placebo controlled evaluation of the safety and efficacy of vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. J Am Geriatr Soc 1987;35:425–30.

38. Peruzza M, DeJacobis M. A double-blind placebo controlled evaluation of the efficacy and safety of vinpocetine in the treatment of patients with chronic vascular or degenerative senile cerebral dysfunction. Adv Ther 1986;3:201–9.

39. Manconi E, Binaghi F, Pitzus F. A double-blind clinical trial of vinpocetine in the treatment of cerebral insufficiency of vascular and degenerative origin. Curr Ther Res Clin Exp 1986;30:702–709.

40. Thal LJ, Salmon DP, Lasker B, et al. The safety and lack of efficacy of vinpocetine in Alzheimer~s disease. J Am Geriatr Soc 1989;37:515–20.

41. Fischhof PK, Moslinger-Gehmayr R, Herrmann WM, et al. Therapeutic efficacy of vincamine in dementia. Neuropsychobiology 1996;34:29–35.

42. Madigan SM, Tracey F, McNulty H, et al. Riboflavin and vitamin B-6 intakes and status and biochemical response to riboflavin supplementation in free-living elderly people. Am J Clin Nutr 1998;68(2):389–95.

43. Tolonen M, Schrijver J, Westermarck T, et al. Vitamin B6 status of Finnish elderly. Comparison with Dutch younger adults and elderly. The effect of supplementation. Int J Vitam Res 1988;58(1):73–7.

44. Deijen JB, van der Beek EJ, Orlebeke JF, et al. Vitamin B-6 supplementation in elderly men: effects on mood, memory, performance and mental effort. Psychopharmacology (Berl) 1992;109(4):489–96.

45. Martin DC, Francis J, Protetch J, Huff FJ. Time dependency of cognitive recovery with cobalamin replacement: report of a pilot study. J Am Geriatr Soc 1992;40(2):168–72.

46. Lindenbaum J, Healton EB, Savage DG, et al. Neuropsychiatric disorders caused by cobalamin deficiency in the absence of anemia or macrocytosis. N Engl J Med 1988;318:1720–8.

47. Myers BL, Badia P. Changes in circadian rhythms and sleep quality with aging: mechanisms and interventions. Neurosci Biobehav Rev 1995;19(4):553–71. Published erratum appears in Neurosci Biobehav Rev 1996;20(2):I–IV.

48. Dollins AB, Zhdanova IV, Wurtman RJ, et al. Effect of inducing nocturnal serum melatonin concentrations in daytime on sleep, mood, body temperature, and performance. Proc Natl Acad Sci U S A 1994;91(5):1824–8.

49. Dori D, Casale G, Solerte SB, et al. Chrono-neuroendocrinological aspects of physiological aging and senile dementia. Chronobiologia 1994;21(1–2):121–6.

50. Comperatore CA, Lieberman HR, Kirby AW, et al. Melatonin efficacy in aviation missions requiring rapid deployment and night operations. Aviat Space Environ Med 1996;67(6):520–4.

51. Jean-Louis G, von Gizycki H, Zizi F. Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment. J Pineal Res 1998;25(3):177–83.

52. Slotten HA, Krekling S. Does melatonin have an effect on cognitive performance? Psychoneuro-endocrinology 1996;21(8):673–80.

53. Masaki KH, Losonczy KG, Izmirlian G, et al. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 2000;54:1265–72.

54. Allain H, Raoul P, Lieury A, et al. Effects of two doses of ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects. Clin Ther 1993;15(3):549–58.

55. Rai GS, Shovlin C, Wesnes KA. A double-blind, placebo-controlled study of Ginkgo biloba extract (‘tanakan’) in elderly patients with mild to moderate memory impairment. Curr Med Res Opin 1991;12(6):350–5.

56. Brautigam MRH, Blommaert FA, Verleye G, et al. Treatment of age-related memory complaints with Ginkgo biloba extract: a randomized double-blind placebo-controlled study. Phytomedicine 1998;5:425–34.

57. Wesnes K, Simmons D, Rook M. A double-blind, placebo-controlled trial of Tanakan in the treatment of idiopathic impairment in the elderly. Human Psychopharmacol 1987;2:159–69.

58. Israel L, Dell’Accio E, Martin G, Hugonot R. Ginkgo biloba extract and memory training programs—comparative assessment on elderly outpatients. Psychologie Médicale 1987;19:1431–9.

59. Gräbel E. The influence of Ginkgo biloba extract (EGb 761) on mental performance: A double-blind study under computerized measurement conditions in patients with cerebral insufficiency. Fortschr Med 1992;110:73–6.

60. Winther K, Randlov C, Rein E, Mehlsen J. Effects of Ginkgo biloba extract on cognitive function and blood pressure in elderly subjects. Curr Ther Res 1998;59:881–8.

61. Van Dongen M, van Rossum E, Kessels AGH, et al. The efficacy of ginkgo for elderly people with dementia and age-associated memory impairment: New results of a randomized clinical trial. J Am Geriatr Soc 2000;48:1183–94.

62. Wang Z, Ren G, Zhao Y, et al. A double-blind study of huperzine A and piracetam in patients with age-associated memory impairment and dementia. In: Kanba S, Richelson E, eds. Herbal Medicines for Nonpsychiatric Diseases. Tokyo: Seiwa Shoten Publishers, 1999, 39–50.

close window

close window



Please login to see wishlist

  • 1. QUA11
  • 2. DU2014
  • 3. ZN38
  • 4. TOPZEN26
  • 5. FNN15
  • 6. ZN40
  • 7. mnm102015
  • 8. DAM15
  • 9. MNM2
  • 10. FIRSTLOVE15
  • 11. MYINDIA
  • 12. FD2015
  • 13. SAK2015
  • 14. WHD2015
  • 15. ZENBIOTIN
  • 16. RAM100
  • 17. ZENITH10ON3
  • 18. ON32015SALE
  • 19. UN3ON
  • 20. ON3ON
  • 21. SSN10ON3U
  • 22. MAGNUS10ON3U
  • 23. VISTA10ON3U
  • 24. ZENITH10ON3U
  • 25. ON32015SALEU
  • 26. UN3ONU
  • 27. ON3ONU
  • 28. ZN5SALE
  • 29. DIWALI100
  • 30. AW2007
  • 31. MGM200MNM
  • 32. XMAS100
  • 33. ON5DJ
  • 34. ON5DJU
  • 35. UN5DJ
  • 36. UN5DJU
  • 37. DJ52015SALE
  • 38. DJ52015SALEU
  • 39. ZENITH10DJ5
  • 40. ZENITH10DJ5U
  • 41. VISTA10DJ5
  • 42. VISTA10DJ5U
  • 43. MAGNUS10DJ5
  • 44. MAGNUS10DJ5U
  • 45. SSN10DJ5
  • 46. SSN10DJ5U
  • 47. SECONDLOVE15
  • 48. HNY2016
  • 49. FAB2016
  • 50. ON5FM9
  • 51. UN5FM9
  • 52. FM92016SALE
  • 53. ZENITH10FM9
  • 54. VISTA10FM9
  • 55. MAGNUS10FM9
  • 56. SSN10FM9
  • 57. ON5FM9U
  • 58. UN5FM9U
  • 59. FM92016SALEU
  • 60. ZENITH10FM9U
  • 61. VISTA10FM9U
  • 62. MAGNUS10FM9U
  • 63. SSN10FM9U
  • 64. FEMINE
  • 65. HEALTHY16
  • 66. ON5AM1
  • 67. ON5AM1U
  • 68. UN5AM1
  • 69. UN5AM1U
  • 70. AM12016SALE
  • 71. AM12016SALEU
  • 72. ZENITH10AM1
  • 73. ZENITH10AM1U
  • 74. VISTA10AM1
  • 75. VISTA10AM1U
  • 76. MAGNUS10AM1
  • 77. MAGNUS10AM1U
  • 78. SSN10AM1
  • 79. SSN10AM1U
  • 80. MOMSGIFT
  • 81. ON5JJ4
  • 82. ON5JJ4U
  • 83. UN5JJ4
  • 84. UN5JJ4U
  • 85. JJ42016SALE
  • 86. JJ42016SALEU
  • 87. ZENITH10JJ4
  • 88. ZENITH10JJ4U
  • 89. VISTA10JJ4
  • 90. VISTA10JJ4U
  • 91. MAGNUS10JJ4
  • 92. MAGNUS10JJ4U
  • 93. SSN10JJ4
  • 94. SSN10JJ4U
  • 95. MYFATHER
  • 96. MAGNUS5
  • 97. EID2016
  • 98. EID100
  • 99. MNM10K8
  • 100. AUG15
  • 101. ON5AS3
  • 102. ON5AS3U
  • 103. UN5AS3
  • 104. UN5AS3U
  • 105. AS32016SALE
  • 106. AS32016SALEU
  • 107. ZENITH10AS3
  • 108. ZENITH10AS3U
  • 109. VISTA10AS3
  • 110. VISTA10AS3U
  • 111. MAGNUS10AS3
  • 112. MAGNUS10AS3U
  • 113. SSN10AS3
  • 114. SSN10AS3U
  • 115. NUTRIWEEK
  • 116. DIWALIFEST
  • 117. ON5ON8
  • 118. ON5ON8U
  • 119. UN5ON8
  • 120. UN5ON8U
  • 121. ON82016SALE
  • 122. ON82016SALEU
  • 123. ZENITH10ON8
  • 124. ZENITH10ON8U
  • 125. VISTA10ON8
  • 126. VISTA10ON8U
  • 127. MAGNUS10ON8
  • 128. MAGNUS10ON8U
  • 129. SSN10ON8
  • 130. SSN10ON8U
  • 131. DD14NOV
  • 132. ON5D1
  • 133. ON5D1U
  • 134. UN5D1
  • 135. UN5D1U
  • 136. D12016SALE
  • 137. D12016SALEU
  • 138. ZENITH10D1
  • 139. ZENITH10D1U
  • 140. VISTA10D1
  • 141. VISTA10D1U
  • 142. MAGNUS10D1
  • 143. MAGNUS10D1U
  • 144. SSN10D1
  • 145. SSN10D1U
  • 146. XMAS200
  • 147. ARU03
  • 148. HNY2017
  • 149. FEB150
  • 150. ONF5M
  • 151. ONF5MU
  • 152. UNF5M
  • 153. UNF5MU
  • 154. F2017MSALE
  • 155. F2017MSALEU
  • 156. ZENITHF10M
  • 157. ZENITHF10MU
  • 158. VISTAF10M
  • 159. VISTAF10MU
  • 160. MAGNUS5F10M
  • 161. MAGNUS5F10MU
  • 162. SSNF10M
  • 163. SSNF10MU
  • 164. MNM150
  • 165. MYHOLI17
  • 166. SUMMER17
  • 167. A2017MSALE4
  • 168. A2017MSALE4U
  • 169. ZENITHA10M4
  • 170. ZENITHA10M4U
  • 171. VISTAA10M4
  • 172. VISTAA10M4U
  • 173. MAGNUSA10M4
  • 174. MAGNUSA10M4U
  • 175. SSNA10M4
  • 176. SSNA10M4U
  • 177. Jainshakti
  • 178. GET150
  • 179. JUNE150
  • 180. 620177SALE3
  • 181. 620177SALE3U
  • 182. ZENITH61073
  • 183. ZENITH61073U
  • 184. VISTA61073
  • 185. VISTA61073U
  • 186. MAGNUS561073
  • 187. MAGNUS561073U
  • 188. SSN61073
  • 189. SSN61073U
  • 190. JULY150

Office located at:

MyNutraMart.com Melting Pot Concepts Private Limited

No.40, 2nd Floor, Sundar Industrial Estate,

New Timber Yard Layout,

Mysore Road, Bangalore - 560026,

Karnataka India.

Landline No: 91-80-26740337, 26742339

Get In Touch

Contact Information

* Required Fields